Senores Pharmaceuticals IPO listing gain & performance.
Issue price, subscription, listing day and what the share did after, from NSE data. Updated every evening.
· data for the trading session of Wed 18 Nov 2026
Senores Pharmaceuticals IPO in brief
Written from NSE’s data, as of 18 Nov 2026.
Senores Pharmaceuticals came to the market at ₹391.00 a share (price band ₹372 to ₹391), with bidding open from 20 December to 24 December 2024. It listed on NSE on Monday, 30 December 2024, opening at ₹600.00, a gain of 53.5% on the issue price, and closed the first day +42.5% from the issue price after trading between +37.8% and +55.9%. 45% of the first day’s traded shares were taken for delivery.
The issue was subscribed 93.7× in total, institutions (QIB) 94.7×, HNIs (NII) 96.3×, retail investors 90.5×. Across the 91 IPOs subscribed 50× or more, the median listing gain was +26.6%.
Its listing gain beat 93% of the 227 main-board IPOs since October 2024, where the median was +7.6%. 1 year after listing it was +110.3% from the issue price and +47.6% from the first-day close, while NIFTY 50 moved +10.5% over the same days. Its highest price so far was 309% above the issue price (24 Aug 2026) and its lowest 11% above it (13 Jan 2025); it closed below the issue price on 0% of the days since listing.
Share price since listing
Daily closes, adjusted for later splits and bonuses. The dashed line is the IPO price.
Subscription
Times subscribed by investor group, NSE + BSE bids as reported by NSE.
For comparison, the median main-board IPO since Oct 2024 was subscribed 28.4× in total.
Listing day
Monday 30 December 2024.
Returns after listing
Against the issue price and the first-day close, with NIFTY 50 and the median IPO for comparison.
| After listing | From issue price | From first-day close | NIFTY 50 | Median IPO (from issue) |
|---|---|---|---|---|
| 1 week6 Jan 2025 | +41.4% | -0.7% | -0.1% | +8.0% |
| 1 month28 Jan 2025 | +28.5% | -9.8% | -2.9% | +9.4% |
| 3 months28 Mar 2025 | +45.9% | +2.4% | -0.5% | +10.3% |
| 6 months2 Jul 2025 | +48.6% | +4.3% | +7.6% | +8.0% |
| 1 year31 Dec 2025 | +110.3% | +47.6% | +10.5% | -8.9% |
IPO details
From NSE’s issue page.
- Company
- Senores Pharmaceuticals
- NSE symbol
- SENORES
- Board
- Main board
- Industry
- Pharmaceuticals
- Bidding
- 20 Dec – 24 Dec 2024
- Price band
- ₹372 to ₹391
- Issue price
- ₹391.00
- Issue size
- Initial Public Offer of Fresh Issue upto 5,000 million and Offer for Sale Up to 21,00,000 Equity Shares (including Anchor Allocation of 66,65,725 Equity Shares)
- Bid lot
- 38 Equity Shares and in multiples thereof
- Listing date
- 30 December 2024
- ISIN
- INE0RB801010
Senores Pharmaceuticals share price, delivery & results →How all IPOs did after listing →IPO calendar →
Questions
What was the listing gain of the Senores Pharmaceuticals IPO?
What is the Senores Pharmaceuticals share price now against the IPO price?
How many times was the Senores Pharmaceuticals IPO subscribed?
When was the Senores Pharmaceuticals IPO open?
From NSE’s issue list and daily price files (adjusted for later splits and bonuses), and subscription as NSE reports it (NSE + BSE bids). Past IPOs do not predict future ones. Information for learning, not investment advice; ChartMine is not a SEBI-registered adviser.
